Multiparticulate Systems of Meloxicam for Colonic Administration in Cancer or Autoimmune Diseases
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14071504
Abstract: The aim of this research is the development of new colonic release systems of meloxicam (MLX) a non-steroidal anti-inflammatory drug (NSAIDs) with pH and time-dependent vehicles for cancer or autoimmune diseases. The colon has a… read more here.
Keywords: cancer autoimmune; multiparticulate systems; autoimmune diseases; systems meloxicam ... See more keywords